All regulations
Nonrulemaking
FDA
Open for Comments
FDA-2022-D-1261
Clostridioides difficile Infection: Developing Drugs for Treatment, Reduction of Recurrence, and Prevention; Draft Guidance for Industry; Availability
Documents
4
Comments
0
Key Dates
Comment Period OpensOct 28, 2022
Comment Period ClosesDec 28, 2022
Documents
Keywords
CDER
Guidance for Industry
Clostridioides difficile Infection
2021-812
Developing Drugs for Treatment
Reduction of Recurrence, and Prevention
OPEN
Data from Regulations.gov